nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinacrine—HNMT—Methylation Pathways—COMT—attention deficit hyperactivity disorder	0.0696	0.252	CbGpPWpGaD
Quinacrine—PLCL1—forebrain—attention deficit hyperactivity disorder	0.056	0.0799	CbGeAlD
Quinacrine—PLA2G6—forebrain—attention deficit hyperactivity disorder	0.0503	0.0718	CbGeAlD
Quinacrine—PLCL1—cardiovascular system—attention deficit hyperactivity disorder	0.0473	0.0676	CbGeAlD
Quinacrine—PLA2G6—cardiovascular system—attention deficit hyperactivity disorder	0.0425	0.0607	CbGeAlD
Quinacrine—PLCL1—midbrain—attention deficit hyperactivity disorder	0.037	0.0528	CbGeAlD
Quinacrine—PLA2G6—midbrain—attention deficit hyperactivity disorder	0.0332	0.0474	CbGeAlD
Quinacrine—HNMT—forebrain—attention deficit hyperactivity disorder	0.0325	0.0464	CbGeAlD
Quinacrine—PLCL1—nervous system—attention deficit hyperactivity disorder	0.0304	0.0434	CbGeAlD
Quinacrine—PLCL1—central nervous system—attention deficit hyperactivity disorder	0.0293	0.0418	CbGeAlD
Quinacrine—PLCL1—cerebellum—attention deficit hyperactivity disorder	0.0286	0.0408	CbGeAlD
Quinacrine—HNMT—cardiovascular system—attention deficit hyperactivity disorder	0.0275	0.0392	CbGeAlD
Quinacrine—PLA2G6—nervous system—attention deficit hyperactivity disorder	0.0273	0.039	CbGeAlD
Quinacrine—PLA2G6—central nervous system—attention deficit hyperactivity disorder	0.0263	0.0375	CbGeAlD
Quinacrine—PLA2G6—cerebellum—attention deficit hyperactivity disorder	0.0257	0.0367	CbGeAlD
Quinacrine—Flurazepam—GABRQ—attention deficit hyperactivity disorder	0.0236	1	CrCbGaD
Quinacrine—PLCL1—brain—attention deficit hyperactivity disorder	0.0232	0.0332	CbGeAlD
Quinacrine—PLA2G6—brain—attention deficit hyperactivity disorder	0.0209	0.0298	CbGeAlD
Quinacrine—PLA2G4A—cardiovascular system—attention deficit hyperactivity disorder	0.0189	0.027	CbGeAlD
Quinacrine—HNMT—nervous system—attention deficit hyperactivity disorder	0.0176	0.0252	CbGeAlD
Quinacrine—HNMT—central nervous system—attention deficit hyperactivity disorder	0.017	0.0242	CbGeAlD
Quinacrine—PLA2G6—Spinal Cord Injury—RTN4—attention deficit hyperactivity disorder	0.0168	0.061	CbGpPWpGaD
Quinacrine—HNMT—cerebellum—attention deficit hyperactivity disorder	0.0166	0.0237	CbGeAlD
Quinacrine—PLA2G4A—midbrain—attention deficit hyperactivity disorder	0.0148	0.0211	CbGeAlD
Quinacrine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0144	0.0522	CbGpPWpGaD
Quinacrine—HNMT—brain—attention deficit hyperactivity disorder	0.0135	0.0192	CbGeAlD
Quinacrine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0122	0.0444	CbGpPWpGaD
Quinacrine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0122	0.0441	CbGpPWpGaD
Quinacrine—PLA2G4A—nervous system—attention deficit hyperactivity disorder	0.0121	0.0173	CbGeAlD
Quinacrine—PLA2G4A—central nervous system—attention deficit hyperactivity disorder	0.0117	0.0167	CbGeAlD
Quinacrine—PLA2G4A—brain—attention deficit hyperactivity disorder	0.00928	0.0132	CbGeAlD
Quinacrine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00844	0.0306	CbGpPWpGaD
Quinacrine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.00721	0.0261	CbGpPWpGaD
Quinacrine—PLA2G6—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00701	0.0254	CbGpPWpGaD
Quinacrine—HNMT—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00648	0.0235	CbGpPWpGaD
Quinacrine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00635	0.0231	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.0059	0.0214	CbGpPWpGaD
Quinacrine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00522	0.00745	CbGeAlD
Quinacrine—SLC22A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.005	0.0181	CbGpPWpGaD
Quinacrine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00441	0.0063	CbGeAlD
Quinacrine—PLA2G6—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00433	0.0157	CbGpPWpGaD
Quinacrine—SLC22A2—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00429	0.0156	CbGpPWpGaD
Quinacrine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.004	0.00571	CbGeAlD
Quinacrine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00385	0.0055	CbGeAlD
Quinacrine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00345	0.00492	CbGeAlD
Quinacrine—PLA2G6—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00344	0.0125	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—STUB1—attention deficit hyperactivity disorder	0.00333	0.0121	CbGpPWpGaD
Quinacrine—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00323	0.0117	CbGpPWpGaD
Quinacrine—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00301	0.0109	CbGpPWpGaD
Quinacrine—PLA2G4A—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00296	0.0107	CbGpPWpGaD
Quinacrine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00283	0.00404	CbGeAlD
Quinacrine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00273	0.00389	CbGeAlD
Quinacrine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00267	0.00381	CbGeAlD
Quinacrine—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00255	0.00927	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00252	0.00916	CbGpPWpGaD
Quinacrine—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0023	0.00835	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00221	0.00803	CbGpPWpGaD
Quinacrine—ABCB1—brain—attention deficit hyperactivity disorder	0.00217	0.00309	CbGeAlD
Quinacrine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00215	0.00781	CbGpPWpGaD
Quinacrine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00196	0.0071	CbGpPWpGaD
Quinacrine—PLA2G4A—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00155	0.00564	CbGpPWpGaD
Quinacrine—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00154	0.00558	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00153	0.00554	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00153	0.00554	CbGpPWpGaD
Quinacrine—PLA2G4A—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00152	0.00553	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.0015	0.00545	CbGpPWpGaD
Quinacrine—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00142	0.00516	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.0014	0.00507	CbGpPWpGaD
Quinacrine—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00133	0.00483	CbGpPWpGaD
Quinacrine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00132	0.0048	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0013	0.00473	CbGpPWpGaD
Quinacrine—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0013	0.00471	CbGpPWpGaD
Quinacrine—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00124	0.00449	CbGpPWpGaD
Quinacrine—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00123	0.00446	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00122	0.00443	CbGpPWpGaD
Quinacrine—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00118	0.00428	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00116	0.00422	CbGpPWpGaD
Quinacrine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.0011	0.00398	CbGpPWpGaD
Quinacrine—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00101	0.00368	CbGpPWpGaD
Quinacrine—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000943	0.00342	CbGpPWpGaD
Quinacrine—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000932	0.00338	CbGpPWpGaD
Quinacrine—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000926	0.00336	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000925	0.00336	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000919	0.00333	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000891	0.00323	CbGpPWpGaD
Quinacrine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000889	0.00322	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000881	0.0032	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000875	0.00317	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000857	0.00311	CbGpPWpGaD
Quinacrine—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00084	0.00305	CbGpPWpGaD
Quinacrine—PLA2G4A—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000801	0.00291	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000771	0.0028	CbGpPWpGaD
Quinacrine—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000761	0.00276	CbGpPWpGaD
Quinacrine—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000756	0.00274	CbGpPWpGaD
Quinacrine—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000751	0.00272	CbGpPWpGaD
Quinacrine—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000714	0.00259	CbGpPWpGaD
Quinacrine—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000709	0.00257	CbGpPWpGaD
Quinacrine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000709	0.00257	CbGpPWpGaD
Quinacrine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000676	0.00245	CbGpPWpGaD
Quinacrine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000662	0.0024	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000618	0.00224	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000602	0.00218	CbGpPWpGaD
Quinacrine—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000596	0.00216	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000594	0.00216	CbGpPWpGaD
Quinacrine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00053	0.00192	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000519	0.00188	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000517	0.00188	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—EP300—attention deficit hyperactivity disorder	0.000513	0.00186	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000506	0.00184	CbGpPWpGaD
Quinacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000506	0.00184	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000497	0.0018	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000483	0.00175	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000468	0.0017	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00046	0.00167	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000454	0.00165	CbGpPWpGaD
Quinacrine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000452	0.00164	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00043	0.00156	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000427	0.00155	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000427	0.00155	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000423	0.00153	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00042	0.00152	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000397	0.00144	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00039	0.00142	CbGpPWpGaD
Quinacrine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000354	0.00128	CbGpPWpGaD
Quinacrine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000352	0.00128	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000351	0.00127	CbGpPWpGaD
Quinacrine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000349	0.00127	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000341	0.00124	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000325	0.00118	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000311	0.00113	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000307	0.00111	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000297	0.00108	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000297	0.00108	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000296	0.00107	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000292	0.00106	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000285	0.00103	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000276	0.001	CbGpPWpGaD
Quinacrine—PLA2G4A—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000273	0.000992	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000272	0.000985	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000272	0.000985	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000268	0.000973	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—COMT—attention deficit hyperactivity disorder	0.000259	0.000938	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000257	0.000931	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00025	0.000906	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000249	0.000903	CbGpPWpGaD
Quinacrine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000247	0.000895	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000237	0.000861	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000235	0.000852	CbGpPWpGaD
Quinacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000227	0.000822	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000226	0.00082	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000215	0.00078	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000215	0.00078	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000211	0.000767	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000197	0.000713	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.00018	0.000653	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000179	0.000648	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000175	0.000635	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000172	0.000623	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000164	0.000593	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000162	0.000588	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000162	0.000588	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00016	0.000579	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000148	0.000538	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000145	0.000525	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.00013	0.000472	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00013	0.00047	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000129	0.000469	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000123	0.000448	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—EP300—attention deficit hyperactivity disorder	0.000111	0.000402	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	9.99e-05	0.000363	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.99e-05	0.000363	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	9.83e-05	0.000357	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	9.83e-05	0.000356	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.76e-05	0.000354	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.27e-05	0.000336	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.14e-05	0.000332	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.99e-05	0.00029	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	7.71e-05	0.00028	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.6e-05	0.000276	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.05e-05	0.00022	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.01e-05	0.000218	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	5.58e-05	0.000203	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.21e-05	0.000153	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.6e-05	9.42e-05	CbGpPWpGaD
